Jim Simons Merrimack Pharmaceuticals Inc Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Merrimack Pharmaceuticals Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 162,184 shares of MACK stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
162,184
Previous 48,900
231.66%
Holding current value
$2.45 Million
Previous $656,000
265.09%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding MACK
# of Institutions
71Shares Held
9.18MCall Options Held
64KPut Options Held
3.2K-
Western Standard LLC Los Angeles, CA2.17MShares$32.9 Million15.49% of portfolio
-
Newtyn Management, LLC New York, NY1.87MShares$28.3 Million5.97% of portfolio
-
Adar1 Capital Management, LLC Austin, TX902KShares$13.7 Million3.02% of portfolio
-
Black Rock Inc. New York, NY723KShares$10.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA621KShares$9.39 Million0.0% of portfolio
About MERRIMACK PHARMACEUTICALS INC
- Ticker MACK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,410,200
- Market Cap $203M
- Description
- Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.